BLAM
ABBV icon

Bourne Lent Asset Management’s AbbVie ABBV Stock Holding History

Bourne Lent Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-16,063
Closed -$940K – 52
2015
Q1 		$940K Buy
+16,063
New +$970K 0.71% 22

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bourne Lent Asset Management's ABBV Position: Q2 2015 in Review

Bourne Lent Asset Management sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 16,063 shares — an estimated $940K sold.

Bourne Lent Asset Management first reported a position in ABBV in Q1 2015 and held it in 1 quarter. The position peaked at $940K in Q1 2015. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

  • Bourne Lent Asset Management reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
  • Bourne Lent Asset Management sold 16,063 AbbVie shares in Q2 2015, an estimated $940K.
  • Bourne Lent Asset Management first reported a position in AbbVie in Q1 2015 and held it in 1 quarter.
  • Bourne Lent Asset Management's AbbVie position peaked at $940K in Q1 2015.
  • 1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Bourne Lent Asset Management's 13F filing for Q2 2015, filed 28 Jul 2015.